. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Phytogenic/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabCamptothecin/analogs & derivativesCamptothecin/therapeutic useCarcinoma, Non-Small-Cell Lung/drug therapyCetuximabColonic Neoplasms/drug therapyColorectal Neoplasms/drug therapyColorectal Neoplasms/secondaryHumansIrinotecanLung Neoplasms/drug therapyPancreatic Neoplasms/drug therapy
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic Agents, PhytogenicBevacizumabIrinotecanCetuximabCamptothecin
Year: 2004 PMID: 15184808
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909